PRESS RELEASE FDA’s Action to remove Trans Fat CAN HELP Prevent CORONARY DISEASE and Save American Lives Statement due to:Steven J. Stack, M.D., President, American Medical Association The American Medical Association commends the U.S. Food and Medication Administration for its decision today to remove partially hydrogenated natural oils, the primary dietary source of artificialtransfat in processed food items, from all U.S. Food products. Last year, we issued aletterin support of the FDA’s efforts to restricttransfat and also urged the FDA to consider additional guidelines to impose strict limits on the amount oftransfat in processed food items. ...continue reading PRESS RELEASE FDA&rsquo.

$10 million from Bill Clinton to fight AIDS Former U.S. President Bill Clinton announced this week that his basis will donate $10 million towards treatment for children with AIDS in the developing world. This will enable AIDS drugs, known as antiretroviral treatment, or Artwork, and technical assist with be sent to 10,000 children in at least 10 countries by the end of the year. India-based drug business Cipla will make the paediatric AIDS medication available at half the normal cost making the Helps drugs available for as little as $140 a calendar year. Clinton says treatment and treatment will now be available and less expensive in the developing world and the initiative that will concentrate on rural areas, will double the real number of HIV-infected children being treated in developing countries besides Thailand and Brazil. ...continue reading $10 million from Bill Clinton to fight AIDS Former U.

2010 European LDN Conference: LDN may be used as effective treatment for those who have MS People with MS and others suffering with a variety of often debilitating inflammatory conditions such as Chronic Exhaustion Fibromyalgia and Syndrome, will need heart from advancements in treatment because of their conditions, and can follow events at The 2nd European LDN Meeting with curiosity. Dealing with opiate addicted sufferers, it had been realised that in low doses, Naltrexone could actually be utilized to improve endorphin levels, effective in the treatment of MS. It had been first used as cure for MS in 1985. As an MS sufferer, Linda Elsegood spent two years bed-bound until treatment with LDN allowed her to regain the use of her motor skills. ...continue reading Will need heart from advancements in treatment because of their conditions.

2012: The Year of the Bugs The Centers for Disease Control and Prevention says 2012 has been the worst year for the West Nile virus since 2003. There have been 2 nearly, 000 cases of the disease so far this season, and 87 Americans have died. The virus offers been reported in 48 claims this year, with almost 45 % of situations in Texas eriacta100.org . Another quarter of all cases have been reported from South Dakota, Mississippi, Oklahoma, Michigan and Louisiana. Also, a Hanta-virus outbreak has killed three visitors to Yosemite National Park. There was a complete case of bubonic plague the other day in Colorado, while a big jump in the tick population could mean an increase in Lyme disease. Dr. William Shaffner, past president of the National Basis for Infectious Illnesses, said the recent up-tick of infectious illnesses is due, partly, to climate. ...continue reading There have been 2 nearly.

Aeterna Zentaris to provide AEZS-108 Phase 2 results for endometrial cancers at EORTC-NCI-AACR Symposium Aeterna Zentaris Inc. AEZS-108, a novel hybrid molecule made up of a synthetic peptide carrier and a well-known chemotherapy agent, doxorubicin, is definitely in a Phase 2 trial in advanced endometrial. To find out more on the trial, go to AEZS-108 may be the first intravenous medication in a clinical study that directs the chemotherapy agent particularly to luteinizing hormone-releasing hormone -receptor expressing tumors, resulting in more targeted treatment with less harm to healthy cells. ...continue reading A novel hybrid molecule made up of a synthetic peptide carrier and a well-known chemotherapy agent.

Because NRTIs & most other drugs have never been examined for long-term side effects, it is highly likely that a great majority of them will eventually be identified as damaging in much the same way as NRTIs. Resources because of this story include:.. AIDS drugs linked to premature aging, dementia, and cardiovascular disease A study recently posted in the journal Nature Genetics explains that nucleoside analog reverse-transcriptase inhibitors, or NRTIs, which are drugs utilized primarily in Africa and various other developing regions of the global world to take care of HIV and AIDS, are in charge of causing cardiovascular disease, dementia, premature aging, and additional age-related illnesses. Originally introduced in the late 1980s, many NRTIs possess since been changed in developed countries by newer, plus much more expensive, antiretroviral drug cocktails which may be as damaging just. ...continue reading AIDS drugs linked to premature aging.

Perhaps having frequent attacks in early life influences the disease fighting capability in order that it is subsequently much more likely to react to gluten, Marild said. The study's findings were published recently in The American Journal of Gastroenterology. However, as the study linked a greater number of infections with an elevated risk of celiac disease, it did not prove a cause-and-effect romantic relationship. It's possible that children who had more attacks were more likely to become diagnosed with celiac simply because they spent much even more time in the health care system, the experts said. ...continue reading Study Links Early Infections to Celiac Risk: FRIDAY.

Her child told Reuters he's concerned about the fitness of his mother. Imagine those years. I have no idea how something like this could affect her body, he said. The rare condition is named lithopedion and occurs when a developing fetus dies during pregnancy and then mummifies beyond your uterus. Previous instances, including one case 2 yrs ago in Colombia, have also involved older women not knowing of the fetus' existence until decades later. Doctors at the Claudio Vicuna Hospital sent Melendez home and said they shall not attempt to remove the fetus, due to the risks of operating on the elderly woman.. ...continue reading She received some very odd news.

82 % of women have at least one factor that puts them at risk for another heart attack In the next year of a Northern California-based survey conducted by Sutter Health on females and heart disease, results show that more women know about coronary attack warning signs and the need to take action quickly. Nevertheless, there remains an alarming disconnect with regards to ladies personalizing their personal risk for cardiovascular disease based on elements such as high blood pressure, raised chlesterol, carrying excess fat and smoking http://viagradanmark.org/kontakt-os.html . According to the most recent survey results, 82 % of ladies in Northern California between the ages of 40 and 70 reported that they have at least one aspect that puts them at risk for a future heart attack. ...continue reading Raised chlesterol.

5. Before you sleep at night, it is vital that you clean and clean your face. The make-up that you used might make your skin itchy and this would also be enough time that your epidermis would be able to breathe. You have to ensure that your face is really clean with the use of a facial cleanser.. 5 Best Things That Teenagers Should Do to Protect Their Skin When they Apply Make Up It is extremely common among girl teens to suffer some complications on the skin and this will be the biggest problem they might have. ...continue reading The social life you have will be affected once you suffer bad skin essentially.

Related StoriesInhalation exposure to PM2.5 pollution triggers liver fibrosisNew prototype air washer reduces existence of pollutants in the atmosphereNitrogen oxides affect pollen of common ragweed plantThese associations had been present at degrees of PM exposure typical in many areas of america. There are few recent studies that analyze air pollution and cognitive function in older adults, but this is actually the first study to examine modification in cognitive function over a period of time and whether contact with the size of particulate matter is important. Jennifer Weuve, MPH., ScD, assistant professor of the Rush Institute of Healthy Ageing and the main investigator of the analysis, along with her colleagues, evaluated air pollution, both fine and coarse, with regards to cognitive decline in older women using a study population from the Nurses' Wellness Study Cognitive Cohort, which included 19,409 U.S. ...continue reading Air pollution might accelerate cognitive decline in older women A large.

Juergen Engel, Ph. D., President and CEO of Aeterna Zentaris stated, 'We are very pleased with AEZS-108 gaining orphan medicinal product designation for ovarian cancers from European authorities, specifically after having been recently granted orphan-drug designation by the FDA. This means that with both these orphan designations, AEZS-108 will be given extra market exclusivity safety in Europe and also in the United States for the treatment of ovarian cancer. We have now look forward to reporting the final outcomes from our ongoing European Phase 2 research in ovarian and endometrial malignancy, later this year.'.. Aeterna Zentaris' AEZS-108 receives orphan medicinal item designation for ovarian tumor in Europe Aeterna Zentaris Inc. ...continue reading A late-stage drug development company specialized in oncology and endocrinology.

For instance, samples containing only 8 % abnormal cells could be confidently analyzed with Agilent's copy number method. The technique was originally developed to improve upon older copy amount assays that use very long genomic fragments such as for example bacterial artificial chromosomes. The method improves upon various other oligonucleotide array assays also, which depend on sample planning methods that remove significant portions of the genomic DNA content. Agilent's higher-resolution system allows users to identify much smaller sized genomic aberrations throughout complex genomes. 'We are thrilled by the latest intellectual property supporting our market-leading CGH array,' said Robert Schueren, Agilent vice president, Genomics. 'This reflects Agilent's continued investment in and dedication to the cytogenetics clinical research space.'.. ...continue reading Agilent awarded patent for comparative genomic hybridization methods Agilent Systems Inc.